Warren M. Kati

6.1k citations

81 papers · 3.5k indexed · h-index 32

Co-authors: Kenneth A. Johnson Karen S. Anderson Rebecca Spence Akhteruzzaman Molla Richard Wolfenden Dale J. Kempf William E. Kohlbrenner Yaya Liu
Topics: HIV/AIDS drug development and treatment (37 papers)Hepatitis C virus research (30 papers)Monoclonal and Polyclonal Antibodies Research (19 papers)
Cited by: Virology Hepatology Infectious Diseases
Journals: Science Journal of the American Chemical Society Journal of Biological Chemistry
Partner nations: United States United Kingdom Australia

In The Last Decade

Warren M. Kati

79 papers receiving 3.4k citations

Peers

Countries citing papers authored by Warren M. Kati

Since Specialization

Citations

This map shows the geographic impact of Warren M. Kati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Warren M. Kati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Warren M. Kati more than expected).

Fields of papers citing papers by Warren M. Kati

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Warren M. Kati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Warren M. Kati. The network helps show where Warren M. Kati may publish in the future.

Co-authorship network of co-authors of Warren M. Kati

This figure shows the co-authorship network connecting the top 25 collaborators of Warren M. Kati. A scholar is included among the top collaborators of Warren M. Kati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Warren M. Kati. Warren M. Kati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Vulnerability of Small-Cell Lung Cancer to Apoptosis Induced by the Combination of BET Bromodomain Proteins and BCL2 Inhibitors 2017 ·Molecular Cancer Therapeutics ·Lloyd T. Lam,Xiaoyu Lin,Emily J. Faivre,Ziping Yang,Xiaoli Huang,Denise M. Wilcox,Richard J. Bellin,Sha Jin,Stephen K. Tahir,Michael J. Mitten,(unknown),Anahita Bhathena,Warren M. Kati,Daniel H. Albert,Yu Shen,Tamar Uziel	55
2	Exploitation of Castration-Resistant Prostate Cancer Transcription Factor Dependencies by the Novel BET Inhibitor ABBV-075 2016 ·Molecular Cancer Research ·Emily J. Faivre,Denise Wilcox,Xia Li,Paul Hessler,Maricel Torrent,Wei He,Tamar Uziel,Daniel H. Albert,Keith F. McDaniel,Warren M. Kati,Yu Shen	53
3	HEXIM1 as a Robust Pharmacodynamic Marker for Monitoring Target Engagement of BET Family Bromodomain Inhibitors in Tumors and Surrogate Tissues 2016 ·Molecular Cancer Therapeutics ·Xiaoyu Lin,Xiaoli Huang,Tamar Uziel,Paul Hessler,Daniel H. Albert,Lisa Roberts-Rapp,Keith F. McDaniel,Warren M. Kati,Yu Shen	45
4	High potency improvements to weak aryl uracil HCV polymerase inhibitor leads 2013 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),John T. Randolph,Peggy Huang,Rolf Wagner,Clarence J. Maring,(unknown),(unknown),Yaya Liu,Rubina Mondal,Jill Beyer,Gennadiy Koev,Kennan C. Marsh,David W. A. Beno,Kenton L. Longenecker,Edward Tam,Warren M. Kati,Akhter Molla,Dale J. Kempf	5
5	Identification of aryl dihydrouracil derivatives as palm initiation site inhibitors of HCV NS5B polymerase 2012 ·Bioorganic & Medicinal Chemistry Letters ·Yaya Liu,(unknown),(unknown),Charles A. Flentge,Douglas K. Hutchinson,Darold L. Madigan,John T. Randolph,Rolf Wagner,Clarence J. Maring,Warren M. Kati,Akhteruzzaman Molla	20
6	Development of a cell-based assay for high-throughput screening of inhibitors against HCV genotypes 1a and 1b in a single well 2009 ·Antiviral Research ·Rubina Mondal,Gennadiy Koev,Edward Tam,Yupeng He,Teresa I. Ng,Warren M. Kati,Akhteruzzaman Molla	14
7	Des-A-ring benzothiadiazines: Inhibitors of HCV genotype 1 NS5B RNA-dependent RNA polymerase 2008 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),(unknown),John K. Pratt,Clarence J. Maring,Warren M. Kati,(unknown),Yaya Liu,Gennadiy Koev,Sherie Masse,Debra Montgomery,Akhter Molla,Dale J. Kempf	16
8	Methods to measure the intracellular concentration of unlabeled compounds within cultured cells using liquid chromatography/tandem mass spectrometry 2008 ·Analytical Biochemistry ·(unknown),Yaya Liu,Gennadiy Koev,Paul L. Richardson,Chih‐Ming Chen,Warren M. Kati	19
9	The emerging field of HCV drug resistance 2008 ·Expert Opinion on Investigational Drugs ·Gennadiy Koev,Warren M. Kati	38
10	Synthesis and SAR of novel 1,1-dialkyl-2(1H)-naphthalenones as potent HCV polymerase inhibitors 2007 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Daniel P. Larson,Rolf Wagner,(unknown),Todd W. Rockway,Warren M. Kati,Yaya Liu,Sherie Masse,Tim Middleton,Hongmei Mo,Debra Montgomery,Wen Jiang,Gennadiy Koev,Dale J. Kempf,Akhter Molla	16
11	Longer wavelength fluorescence resonance energy transfer depsipeptide substrates for hepatitis C virus NS3 protease 2007 ·Analytical Biochemistry ·Alex K. Konstantinidis,Paul L. Richardson,(unknown),Rakesh Tripathi,Chih‐Ming Chen,Peggy Huang,John T. Randolph,(unknown),(unknown),Usha Warrior,Tim Middleton,Warren M. Kati	9
12	A replicon-based shuttle vector system for assessing the phenotype of HCV NS5B polymerase genes isolated from patient populations 2007 ·Journal of Virological Methods ·Tim Middleton,Yupeng He,Edward Tam,Rakesh Tripathi,(unknown),Andrew Roth,Chih‐Ming Chen,Gennadiy Koev,Teresa I. Ng,Preethi Krishnan,Ron Pithawalla,Rubina Mondal,Tatyana Dekhtyar,Liangjun Lu,Hongmei Mo,Warren M. Kati,Akhteruzzaman Molla	25
13	Inhibitors of HCV NS5B polymerase: Synthesis and structure–activity relationships of N-1-benzyl and N-1-[3-methylbutyl]-4-hydroxy-1,8-naphthyridon-3-yl benzothiadiazine analogs containing substituents on the aromatic ring 2006 ·Bioorganic & Medicinal Chemistry Letters ·Todd W. Rockway,Rong Zhang,Dachun Liu,David A. Betebenner,Keith F. McDaniel,John K. Pratt,David W. A. Beno,Debra Montgomery,(unknown),Sherie Masse,Warren M. Kati,Tim Middleton,Akhteruzzaman Molla,Clarence J. Maring,Dale J. Kempf	22
14	Replication efficiency of chimeric replicon containing NS5A–5B genes derived from HCV-infected patient sera 2006 ·Antiviral Research ·Rakesh Tripathi,Preethi Krishnan,Yupeng He,Tim Middleton,Edward Tam,Chih‐Ming Chen,Daryl Lau,Stanley M. Lemon,Hongmei Mo,Warren M. Kati,Akhteruzzaman Molla	27
15	Inhibitors of HCV NS5B polymerase: synthesis and structure–activity relationships of N-1-heteroalkyl-4-hydroxyquinolon-3-yl-benzothiadiazines 2005 ·Bioorganic & Medicinal Chemistry Letters ·John K. Pratt,(unknown),Keith F. McDaniel,Clarence J. Maring,Warren M. Kati,Hongmei Mo,Tim Middleton,Yaya Liu,Teresa I. Ng,(unknown),Rong Zhang,Debra Montgomery,Akhteruzzaman Molla,Dale J. Kempf,William E. Kohlbrenner	28
16	Conserved residues in the coiled-coil pocket of human immunodeficiency virus type 1 gp41 are essential for viral replication and interhelical interaction 2004 ·Virology ·Hongmei Mo,Alex K. Konstantinidis,Kent D. Stewart,Tatyana Dekhtyar,Teresa I. Ng,Kerry M. Swift,Edmund D. Matayoshi,Warren M. Kati,William E. Kohlbrenner,Akhteruzzaman Molla	38
17	Design, synthesis, and structural analysis of inhibitors of influenza neuraminidase containing a 2,3-disubstituted tetrahydrofuran-5-carboxylic acid core 2004 ·Bioorganic & Medicinal Chemistry Letters ·Gary T. Wang,Sheldon Wang,Robert G. Gentles,Thomas J. Sowin,Clarence J. Maring,Dale J. Kempf,Warren M. Kati,Vincent S. Stoll,Kent D. Stewart,Graeme Laver	16
18	GS4071 Is a Slow-Binding Inhibitor of Influenza Neuraminidase from Both A and B Strains 1998 ·Biochemical and Biophysical Research Communications ·Warren M. Kati,(unknown),(unknown),Hing L. Sham,W.G. Laver,William E. Kohlbrenner	39
19	Novel Triterpene Sulfates from Fusarium compactum Using a Rhinovirus 3C Protease Inhibitor Screen. 1996 ·The Journal of Antibiotics ·(unknown),Warren M. Kati,Debra Montgomery,James P. Karwowski,(unknown),(unknown),(unknown),Sunil Kadam,(unknown),James B. McAlpine	17
20	Design, structure-activity, and molecular modeling studies of potent renin inhibitory peptides having N-terminal Nin-For-Trp (Ftr): angiotensinogen congeners modified by P1-P1' Phe-Phe, Sta, Leu.psi.[CH(OH)CH2]Val or Leu.psi.[CH2NH]Val substitutions 1988 ·Journal of Medicinal Chemistry ·Tomi K. Sawyer,Donald T. Pals,Boryeu Mao,Douglas J. Staples,(unknown),Linda Maggiora,Joseph A. Affholter,Warren M. Kati,David J. Duchamp	31

About Warren M. Kati

Warren M. Kati is a scholar working on Hepatology, Infectious Diseases and Virology, having authored 81 papers that have together received 3.5k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (37 papers), Hepatitis C virus research (30 papers) and Monoclonal and Polyclonal Antibodies Research (19 papers). The work is most often cited by research in Virology (791 citations), Hepatology (724 citations) and Infectious Diseases (1.4k citations). Warren M. Kati has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Kenneth A. Johnson, Karen S. Anderson, Rebecca Spence, Akhteruzzaman Molla, Richard Wolfenden, Dale J. Kempf, William E. Kohlbrenner, Yaya Liu, Donald T. Pals and Clarence J. Maring. Their work appears in journals such as Science, Journal of the American Chemical Society and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact